Results 71 to 80 of about 815 (103)

SARS-CoV-2 infection induces pro-fibrotic and pro-thrombotic foam cell formation. [PDF]

Nat Microbiol
Battaglia DM, Post CE, Yao W, Wahl A, Gralinski LE, Liu H, Dang H, Madden VJ, White KK, Leist SR, Dinnion KH, De la Cruz G, Midkiff BR, Froggatt HM, Gully K, Zweigart M, Reader JR, Olstad KJ, Everitt JI, Van Rompay KKA, De Paris K, Sajti E, Pickles RJ, Browne EP, Jones CD, Boucher RC, Baric RS, Garcia JV.   +27 more
europepmc   +1 more source

Development of a stable replicon system of a pangolin merbecovirus for antiviral screening. [PDF]

Virol Sin
Wu CG, Wang JH, Zhu B, Chen J.
europepmc   +1 more source

Divergent sustainability profiles of molnupiravir synthesis routes are governed by solvent use and process design. [PDF]

Proc Natl Acad Sci U S A
Chen Z, Lian JZ, Huang H, Zhu H, Kanye LT, Chen M, Zhang Z, Liu B, Zhang J, Ahmed A, Barbarossa V, Cucurachi S, Dong B.   +12 more
europepmc   +1 more source

Targeting the Rift Valley Fever Virus Polymerase: Resistance Mechanisms and Structural Insights. [PDF]

ACS Infect Dis
Král' M, Das A, Kotačka T, Blahošová A, Liščáková V, Hodek J, Konvalinka J, Demo G, Kožíšek M.   +8 more
europepmc   +1 more source

Development of GFP-expressing infectious clones for PRRSV using TAR cloning for antiviral drug screening. [PDF]

Npj Viruses
Zhang M, Qian B, Kunec D, Veit M.
europepmc   +1 more source

Oral pharmacokinetics and efficacy of oral phospholipid remdesivir nucleoside prodrugs against SARS-CoV-2 in mice. [PDF]

Antimicrob Agents Chemother
Carlin AF, Beadle JR, Ardanuy J, Clark AE, Rhodes V, Garretson AF, Murphy JA, Valiaeva N, Schooley RT, Frieman MB, Hostetler KY.   +10 more
europepmc   +1 more source

A Validated Eco-Friendly High-Performance Liquid Chromatography Assay for Therapeutic Drug Monitoring of GS-441524 in Cats with Feline Infectious Peritonitis. [PDF]

Pathogens
Cooke SW, Hammond R, Gunn-Moore DA.
europepmc   +1 more source

Carboxylesterase Factors Influencing the Therapeutic Activity of Common Antiviral Medications Used for SARS-CoV-2 Infection. [PDF]

Pharmaceutics
Shen Y, Eades W, Dinh L, Yan B.
europepmc   +1 more source

Lysosomal "TRAP": a neotype modality for clearance of viruses and variants. [PDF]

Nat Commun
Lyu C, He Z, Hu X, Wang S, Qin M, Zhu L, Li Y, Yang F, Jiao Z, Zhang X, Lu G, Wang E, Hu Y, Zhai Y, Wang Y, Huang W, Wang D, Cui Y, Pang X, Liu X, Kamiya H, Ma G, Wei W, Wei W.   +23 more
europepmc   +1 more source

Advancements in the development of antivirals against SARS-Coronavirus. [PDF]

Front Cell Infect Microbiol
Kumar M, Baig MS, Bhardwaj K.
europepmc   +1 more source